102 related articles for article (PubMed ID: 24823909)
1. The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer.
Stockley J; Villasevil ME; Nixon C; Ahmad I; Leung HY; Rajan P
RNA Biol; 2014; 11(6):755-65. PubMed ID: 24823909
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation regulates hnRNPA2 granule protein partitioning and reduces neurodegeneration.
Ryan VH; Perdikari TM; Naik MT; Saueressig CF; Lins J; Dignon GL; Mittal J; Hart AC; Fawzi NL
EMBO J; 2021 Feb; 40(3):e105001. PubMed ID: 33349959
[TBL] [Abstract][Full Text] [Related]
3. Keratin 19 binds and regulates cytoplasmic HNRNPK mRNA targets in triple-negative breast cancer.
Fallatah A; Anastasakis DG; Manzourolajdad A; Sharma P; Wang X; Jacob A; Alsharif S; Elgerbi A; Coulombe PA; Hafner M; Chung BM
BMC Mol Cell Biol; 2023 Aug; 24(1):26. PubMed ID: 37592256
[TBL] [Abstract][Full Text] [Related]
4. Weak binding to the A2RE RNA rigidifies hnRNPA2 RRMs and reduces liquid-liquid phase separation and aggregation.
Ryan VH; Watters S; Amaya J; Khatiwada B; Venditti V; Naik MT; Fawzi NL
Nucleic Acids Res; 2020 Oct; 48(18):10542-10554. PubMed ID: 32870271
[TBL] [Abstract][Full Text] [Related]
5. Kapβ2 Inhibits Perioperative Neurocognitive Disorders in Rats with Mild Cognitive Impairment by Reversing the Nuclear-Cytoplasmic Mislocalization of hnRNPA2/B1.
Zhang M; Jia F; Wang Q; Yang C; Wang X; Liu T; Tang Q; Yang Z; Wang H
Mol Neurobiol; 2023 Dec; ():. PubMed ID: 38102516
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of δ-catenin palmitoylation slows the progression of prostate cancer.
Wang B; Zhou R; Wu J; Kim H; Kim K
Biochim Biophys Acta Mol Cell Res; 2024 Apr; 1871(5):119741. PubMed ID: 38697304
[TBL] [Abstract][Full Text] [Related]
7. Novel role of hnRNP-A2/B1 in modulating aryl hydrocarbon receptor ligand sensitivity.
Cho SW; Suzuki K; Miura Y; Miyazaki T; Nose M; Iwata H; Kim EY
Arch Toxicol; 2015 Nov; 89(11):2027-38. PubMed ID: 25224401
[TBL] [Abstract][Full Text] [Related]
8. Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.
Kasim M; Benko E; Winkelmann A; Mrowka R; Staudacher JJ; Persson PB; Scholz H; Meier JC; Fähling M
J Biol Chem; 2014 Sep; 289(39):26973-26988. PubMed ID: 25124043
[TBL] [Abstract][Full Text] [Related]
9. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
10. hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells.
Pérez-Boza J; Boeckx A; Lion M; Dequiedt F; Struman I
Cell Mol Life Sci; 2020 Nov; 77(21):4413-4428. PubMed ID: 31894362
[TBL] [Abstract][Full Text] [Related]
11. The roles of hnRNP A2/B1 in RNA biology and disease.
Liu Y; Shi SL
Wiley Interdiscip Rev RNA; 2021 Mar; 12(2):e1612. PubMed ID: 32588964
[TBL] [Abstract][Full Text] [Related]
12. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.
Alarcón CR; Goodarzi H; Lee H; Liu X; Tavazoie S; Tavazoie SF
Cell; 2015 Sep; 162(6):1299-308. PubMed ID: 26321680
[TBL] [Abstract][Full Text] [Related]
13. Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells.
Tummala R; Lou W; Gao AC; Nadiminty N
Mol Cancer Ther; 2017 Dec; 16(12):2770-2779. PubMed ID: 28729398
[TBL] [Abstract][Full Text] [Related]
14. NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.
Nadiminty N; Tummala R; Liu C; Lou W; Evans CP; Gao AC
Mol Cancer Ther; 2015 Aug; 14(8):1884-95. PubMed ID: 26056150
[TBL] [Abstract][Full Text] [Related]
15. Control of Selective mRNA Translation in Neuronal Subcellular Compartments in Health and Disease.
Cagnetta R; Flanagan JG; Sonenberg N
J Neurosci; 2023 Nov; 43(44):7247-7263. PubMed ID: 37914402
[TBL] [Abstract][Full Text] [Related]
16. CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer.
Lu Y; Zou R; Gu Q; Wang X; Zhang J; Ma R; Wang T; Wu J; Feng J; Zhang Y
Cell Death Dis; 2023 Sep; 14(9):611. PubMed ID: 37716979
[TBL] [Abstract][Full Text] [Related]
17. CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
[TBL] [Abstract][Full Text] [Related]
18. SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses.
Zhu S; Hou J; Gao H; Hu Q; Kloeber JA; Huang J; Zhao F; Zhou Q; Luo K; Wu Z; Tu X; Yin P; Lou Z
Mol Cell; 2023 Feb; 83(4):539-555.e7. PubMed ID: 36702126
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets.
Lu Y; Wang X; Gu Q; Wang J; Sui Y; Wu J; Feng J
Cell Death Discov; 2022 Jul; 8(1):337. PubMed ID: 35879279
[TBL] [Abstract][Full Text] [Related]
20. Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review).
Wan H; Feng Y; Wu J; Zhu L; Mi Y
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35856412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
